LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX
· Real-Time Price · USD
1.52
-0.02 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
1.52
-0.33%
After-hours: Aug 15, 2025, 04:04 PM EDT
LAVA Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 4.99M | 11.98M | 7.34M | 7.4M | 12.54M | 6.77M | 9.06M | 24.26M | 19.59M | 19.39M | 17.82M | 4.65M | 5.26M | 5.24M | 5.94M | 4.81M | 4.4M |
Cost of Revenue | 456K | 456K | 382K | 392K | 2.55M | 3.48M | 3.33M | 3.32M | 930K | n/a | 6.63M | 13.34M | 18.23M | 36.94M | 34.63M | 31.79M | 30.35M |
Gross Profit | 4.76M | 11.75M | 6.96M | 7.01M | 9.98M | 3.29M | 5.73M | 20.95M | 18.66M | 19.39M | 11.18M | -8.69M | -12.97M | -31.7M | -28.69M | -26.98M | -25.95M |
Operating Income | -27.74M | -29.69M | -28.04M | -27.48M | -31.67M | -43.25M | -49.29M | -40.13M | -37.66M | -34.84M | -32.7M | -39.49M | -34.99M | -43.72M | -37.2M | -32.5M | -29.46M |
Interest Income | 3.66M | 3.76M | 3.27M | 3.28M | 3.16M | 2.97M | 2.6M | 1.82M | 1.22M | 600K | 280K | 399K | 309K | 309K | 255.35K | 205.23K | 269.28K |
Pretax Income | -27.7M | -24.48M | -27.33M | -23.92M | -28.31M | -41.7M | -50.11M | -40.34M | -35.76M | -31.66M | -24.97M | -32.84M | -32.82M | -42.77M | -37.22M | -34.27M | -30.17M |
Net Income | -28.04M | -25.11M | -27.64M | -24.18M | -28.59M | -41.97M | -50.39M | -40.62M | -36.02M | -31.91M | -25.21M | -33.08M | -33.01M | -42.93M | -37.37M | -34.37M | -30.23M |
Selling & General & Admin | 13.72M | 13.22M | 11.03M | 11.1M | 11.77M | 12.73M | 14.02M | 14.3M | 13.78M | 14.12M | 14.31M | 14.94M | 14.53M | 12.02M | 8.51M | 5.52M | 3.51M |
Research & Development | 26.6M | 28.45M | 24.2M | 23.62M | 29.88M | 33.81M | 40.99M | 46.78M | 42.55M | 40.1M | 36.2M | 29.2M | 25.73M | 36.94M | 34.63M | 31.79M | 30.35M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 40.15M | 40.84M | 36.41M | 34.77M | 41.46M | 47.95M | 58.43M | 63.11M | 55.46M | 51.31M | 35.79M | 23.6M | 19.19M | 10.45M | 8.05M | 6.87M | 3.91M |
Interest Expense | 644K | 515K | n/a | n/a | n/a | n/a | n/a | n/a | 90K | 253K | 385.04K | 571.78K | 668.78K | 634.78K | 629.54K | 550.81K | 427.91K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 40.32M | 41.02M | 36.57M | 34.93M | 44.01M | 51.43M | 61.76M | 66.43M | 56.39M | 51.31M | 42.42M | 36.93M | 37.42M | 47.39M | 42.68M | 38.66M | 34.26M |
Income Tax Expense | 336K | 630K | 311K | 265K | 277K | 279K | 285K | 282K | 261K | 249K | 239K | 236K | 192K | 157K | 143K | 99K | 70.37K |
Shares Outstanding (Basic) | 26.89M | 26.87M | 26.85M | 26.82M | 26.79M | 26.77M | 26.29M | 26.29M | 26.29M | 26.29M | 25.85M | 25.78M | 25.78M | 25.78M | 25.68M | 25.52M | 25.52M |
Shares Outstanding (Diluted) | 26.89M | 26.87M | 26.85M | 26.82M | 26.79M | 26.77M | 26.29M | 26.29M | 26.29M | 26.29M | 26.45M | 25.78M | 25.78M | 25.78M | 25.78M | 25.52M | 25.52M |
EPS (Basic) | -1.05 | -0.94 | -1.03 | -0.91 | -1.08 | -1.59 | -1.92 | -1.54 | -1.37 | -1.22 | -0.97 | -1.28 | -1.28 | -1.67 | -10.79 | -19.89 | -28.29 |
EPS (Diluted) | -1.05 | -0.94 | -1.03 | -0.91 | -1.08 | -1.59 | -1.92 | -1.54 | -1.37 | -1.22 | -0.97 | -1.28 | -1.28 | -1.67 | -10.79 | -19.89 | -28.29 |
EBITDA | -23.68M | -25.49M | -27.38M | -26.88M | -31.04M | -42.45M | -48.48M | -39.38M | -36.95M | -34.33M | -32.28M | -39.1M | -34.85M | -43.61M | -38.24M | -33.56M | -30.33M |
EBIT | -24.02M | -25.97M | -26.25M | -25.69M | -29.88M | -41.46M | -46.11M | -36.95M | -34.48M | -31.66M | -33.93M | -40.72M | -37.47M | -46.34M | -39.98M | -35.45M | -31.47M |
Depreciation & Amortization | -144K | n/a | 767K | 707K | 631K | 616K | 622K | 575K | 532K | 504K | 411K | 393K | 361K | 331K | 282.86K | 259.18K | 232.75K |